X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (33) 33
humans (24) 24
male (23) 23
aged (17) 17
female (16) 16
middle aged (15) 15
cardiac & cardiovascular systems (11) 11
cardiovascular (11) 11
aged, 80 and over (10) 10
abridged index medicus (8) 8
animals (8) 8
medical colleges (8) 8
treatment outcome (8) 8
adult (7) 7
ophthalmology (7) 7
peripheral vascular disease (7) 7
care and treatment (6) 6
time factors (6) 6
analysis (5) 5
cancer (5) 5
cardiology (5) 5
cardiology and cardiovascular medicine (5) 5
internal medicine (5) 5
ischemia (5) 5
mortality (5) 5
neurology (5) 5
neurosciences (5) 5
risk factors (5) 5
rodents (5) 5
disease progression (4) 4
fibrinolytic agents - therapeutic use (4) 4
heart failure (4) 4
infections (4) 4
rats (4) 4
retrospective studies (4) 4
stroke - drug therapy (4) 4
studies (4) 4
blood-pressure (3) 3
brain ischemia - drug therapy (3) 3
cardiomyopathy (3) 3
cohort studies (3) 3
critical care medicine (3) 3
disease models, animal (3) 3
electrocardiography (3) 3
fibrinolytic agents - administration & dosage (3) 3
follow-up (3) 3
hospitals (3) 3
hypertension (3) 3
immunohistochemistry (3) 3
in-vivo (3) 3
intensive care (3) 3
intracerebral hemorrhage (3) 3
japan - epidemiology (3) 3
mice (3) 3
mice, inbred c57bl (3) 3
microglial activation (3) 3
natriuretic peptide (3) 3
neurology. diseases of the nervous system (3) 3
patients (3) 3
population (3) 3
prevalence (3) 3
prospective studies (3) 3
proteins (3) 3
retinitis pigmentosa (3) 3
sepsis (3) 3
stroke (3) 3
surgery (3) 3
therapy (3) 3
tissue plasminogen activator (3) 3
tissue plasminogen activator - administration & dosage (3) 3
tissue plasminogen activator - therapeutic use (3) 3
0.6 mg/kg (2) 2
abdomen (2) 2
activation (2) 2
acute ischemic stroke (2) 2
alleles (2) 2
alteplase (2) 2
anesthesiology (2) 2
antibiotics (2) 2
aqueous humor - metabolism (2) 2
article (2) 2
bnp (2) 2
body mass index (2) 2
cardiomyocytes (2) 2
cardiovascular agents (2) 2
cardiovascular disease (2) 2
cataract (2) 2
cell count (2) 2
cholesterol (2) 2
chronic kidney-disease (2) 2
clinical neurology (2) 2
comorbidity (2) 2
congestive-heart-failure (2) 2
cricetinae (2) 2
critical care (2) 2
cystoid macular edema (2) 2
cytokines (2) 2
cytoskeletal proteins - genetics (2) 2
data interpretation, statistical (2) 2
development and progression (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Ophthalmology, ISSN 0161-6420, 2010, Volume 117, Issue 11, pp. 2229 - 2232
Purpose To examine Müller's muscle's horizontal extensions in relation to the peribulbar smooth muscle network. Design Observational anatomic study.... 
Ophthalmology
Journal Article
Ophthalmology, ISSN 0161-6420, 2013, Volume 120, Issue 1, pp. e5 - e12
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2009, Volume 53, Issue 19, pp. 1814 - 1822
Journal Article
Journal Article
Journal of Stroke and Cerebrovascular Diseases, ISSN 1052-3057, 2013, Volume 22, Issue 7, pp. 1175 - 1183
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2007, Volume 50, Issue 5, pp. 453 - 462
Journal Article
Journal of Stroke and Cerebrovascular Diseases, ISSN 1052-3057, 2013, Volume 22, Issue 3, pp. 190 - 196
In October 2005 in Japan, the recombinant tissue plasminogen activator (tPA) alteplase was approved for patients with acute ischemic stroke within 3 hours of... 
Neurology | Cardiovascular | intracerebral hemorrhage | cardiogenic embolism | tPA | acute ischemic stroke | DWI-ASPECTS | edaravone | warfarin | RATS | NEUROSCIENCES | BRAIN EDEMA | ALTEPLASE | PERIPHERAL VASCULAR DISEASE | MCI-186 | CEREBRAL-ISCHEMIA | 0.6 MG/KG | Recombinant Proteins - therapeutic use | Japan - epidemiology | Predictive Value of Tests | Humans | Middle Aged | Stroke - diagnosis | Warfarin - adverse effects | Male | Tissue Plasminogen Activator - therapeutic use | Tissue Plasminogen Activator - adverse effects | Incidence | Fibrinolytic Agents - adverse effects | Time Factors | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Adult | Female | Stroke - epidemiology | Retrospective Studies | Odds Ratio | Brain Ischemia - epidemiology | Disability Evaluation | Risk Assessment | Time-to-Treatment | Risk Factors | Logistic Models | Tissue Plasminogen Activator - administration & dosage | Treatment Outcome | Stroke - drug therapy | Anticoagulants - adverse effects | Chi-Square Distribution | International Normalized Ratio | Administration, Intravenous | Hospitals | Cerebral Hemorrhage - epidemiology | Brain Ischemia - drug therapy | Diffusion Magnetic Resonance Imaging | Brain Ischemia - diagnosis | Aged | Fibrinolytic Agents - administration & dosage | Thrombolytic Therapy - adverse effects | Sects | Medical colleges | Care and treatment | Warfarin | Ischemia | Tissue plasminogen activator | Index Medicus
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 60, Issue 16, pp. 1558 - 1565
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 57, Issue 12, pp. 1386 - 1395
Objectives The purpose of this study was to investigate circulating pro–B-type natriuretic peptide (proBNP1–108 ) in the general community and evaluate its... 
Cardiovascular | Internal Medicine | heart failure | natriuretic peptide | NT-proBNP | biomarker | BNP | proBNP
Journal Article